Printer Friendly

Market Report, "Viventia Biotechnologies Inc. - Product Pipeline Review - 2013", published.

[USPRwire, Fri Aug 16 2013] Global Markets Direct's pharmaceuticals report, "Viventia Biotechnologies Inc. - Product Pipeline Review - 2013" provides data on the Viventia Biotechnologies Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Viventia Biotechnologies Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Viventia Biotechnologies Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


* Viventia Biotechnologies Inc. - Brief Viventia Biotechnologies Inc. overview including business description, key information and facts, and its locations and subsidiaries.

* Review of current pipeline of Viventia Biotechnologies Inc. human therapeutic division.

* Overview of pipeline therapeutics across various therapy areas.

* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

* Product profiles for late stage and clinical stage products of Viventia Biotechnologies Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

* Recent updates of the Viventia Biotechnologies Inc.'s pipeline in the last quarter.

* Key discontinued and dormant projects.

* Latest news and deals relating to the products.

Full Report Details at


Reasons to Get this Report

* Evaluate Viventia Biotechnologies Inc.'s strategic position with total access to detailed information on its product pipeline.

* Assess the growth potential of Viventia Biotechnologies Inc. in its therapy areas of focus.

* Identify new drug targets and therapeutic classes in the Viventia Biotechnologies Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

* Exploit collaboration and partnership opportunities with Viventia Biotechnologies Inc..

* Avoid Intellectual Property Rights related issues.

* Explore the dormant and discontinued projects of Viventia Biotechnologies Inc. and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Viventia Biotechnologies Inc. - Product Pipeline Review - 2012

- Carcinomas - Pipeline Review, H1 2013

- Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2013

- Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013

- Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2013

Copyright 2013 USPRwire

Provided by an company
COPYRIGHT 2013 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Date:Aug 16, 2013
Previous Article:New Market Research Report: Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2013.
Next Article:Soligenix, Inc. - Product Pipeline Review - 2013 - New Study Released.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters